Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 701–800 of 1,003
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
Wilke, C. M., Wang, L., Wei, S., Kryczek, I., Huang, E. H., Kao, J. Y., Lin, Y., Fang, J., & Zou, W. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-217 · Cited by 43
“Th17 cells play a role in the inflammatory response associated with multiple human autoimmune diseases [4,41-43] and cancer [8,9].”
BackgroundAberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma
Lu, T., Yu, S., Liu, Y., Yin, C., Ye, J., Liu, Z., Ma, D., & Ji, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148044 · Cited by 38
Freundt-Revilla, J., Maiolini, A., Carlson, R., Beyerbach, M., Rentmeister, K., Flegel, T., Fischer, A., & Tipold, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0784-3 · Cited by 44
“Interestingly, the mechanisms by which IL-17 disrupts the tight junctions between the endothelial cells of the blood-brain barrier (BBB) were recently demonstrated and the ability of Th17 cells to transmigrate efficiently across the BBB was proven [30].”
BackgroundFingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
Friess, J., Hecker, M., Roch, L., Koczan, D., Fitzner, B., Angerer, I. C., Schröder, I., Flechtner, K., Thiesen, H., Winkelmann, A., et al. (2017) · Scientific Reports · doi:10.1038/srep42087 · Cited by 42
Modulation of PKM Activity Controls Differentiation of Th17 Cells
Seki, S. M., Posyniak, K., McCloud, R. L., Rosen, D. A., Fernández-Castañeda, A., Beiter, R. M., Serbulea, V., Nanziri, S. C., Hayes, N. W., Spivey, C., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aay9217 · Cited by 43
Tseng, W. C., Reinhart, V., Lanz, T. A., Weber, M. L., Pang, J., Le, K. X., Bell, R. D., O’Donnell, P., & Buhl, D. L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01262-5 · Cited by 41
Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis
Atabati, H., Yazdanpanah, E., Mortazavi, H., Bajestani, S. G., Raoofi, A., Esmaeili, S., Khaledi, A., Saburi, E., Afshari, J. T., Sathyapalan, T., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_6 · Cited by 40
Demeestere, D., Libert, C., & Vandenbroucke, R. E. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.010 · Cited by 43
Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response
Zhang, X., & Markovic‐Plese, S. (2008) · Immunologic Research · doi:10.1007/s12026-008-8019-z · Cited by 38
“Th17 cells are recently identified subset of CD4+ T cells that plays a critical role in the development of autoimmune diseases [42, 43 ].”
BackgroundFunctional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia
Debnath, M., & Berk, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0309-1 · Cited by 43
Barkaway, A., Attwell, D., & Korte, N. (2022) · Neurophotonics · doi:10.1117/1.nph.9.3.031914 · Cited by 39
Meyer‐Arndt, L., Kerkering, J., Kuehl, T., Infante, A. G., Paul, F., Rosiewicz, K. S., Siffrin, V., & Alisch, M. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10059-w · Cited by 50
Th17 Cells, Glucocorticoid Resistance, and Depression
Khantakova, J. N., Mutovina, A., Ayriyants, K. A., & Bondar, N. P. (2023) · Cells · doi:10.3390/cells12232749 · Cited by 38
Schneider, H., Errede, M., Ulrich, N. H., Virgintino, D., Frei, K., & Bertalanffy, H. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31821bc40e · Cited by 38
“Additionally, occludin phosphorylation correlates with TJ formation and regulation of junction permeability and interaction with ZO-1 (53-55).”
BackgroundImunopatologia da dermatite de contato alérgica
Martins, L. E. A. M., & dos Reis, V. M. S. (2011) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962011000300001 · Cited by 50
McLaughlin, P. J., McHugh, D. P., Magister, M. J., & Zagon, I. S. (2015) · BMC Immunology · doi:10.1186/s12865-015-0093-0 · Cited by 42
“Th1 cells are often considered proinflammatory, respond to IL-12, and produce IFN-γ, which enhances the pathway of CD4+ T cell proliferation and inflammation [5,15,16].”
BackgroundPathogenesis of Pediatric Multiple Sclerosis
Vargas-Lowy, D., & Chitnis, T. (2012) · Journal of Child Neurology · doi:10.1177/0883073812456084 · Cited by 40
“Recent immunologic data suggest that TH17 cells are particularly adept at interacting with, and trafficking across, the human blood-brain barrier.(75,76) It remains unclear whether overly proinflammatory T-cell responses represent a primary/initiating defect, or one that reflects chronic immune dysregulation later in…”
BackgroundSevera, M., Rizzo, F., Giacomini, E., Salvetti, M., & Coccia, E. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.005 · Cited by 41
“transmigrate across BBB endothelial cells leading to the destruction of human neurons and initiating CNS inflammation through T cell recruitment [49].”
BackgroundMetcalfe, S. M., Strom, T. B., Williams, A., & Fahmy, T. M. (2015) · Nanobiomedicine · doi:10.5772/60622 · Cited by 37
Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study
Tseng, C., Chang, S., Tsai, W., Ou, T., Wu, C., Sung, W., Hsieh, M., & Yen, J. (2016) · Medicine · doi:10.1097/md.0000000000003999 · Cited by 45
Cerium Oxide Nanoparticles for the Treatment of Neurological Oxidative Stress Diseases
Estevez, A. Y., & Erlichman, J. S. (2011) · ACS symposium series · doi:10.1021/bk-2011-1083.ch009 · Cited by 43
Vergaelen, E., Schiweck, C., Steeland, K. V., Counotte, J., Veling, W., Swillen, A., Drexhage, H. A., & Claes, S. J. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.022 · Cited by 45
“Impaired hippocampal neurogenesis could be restored upon adoptive transfer with homogenous Th17 populations enriched for myelin-reactive T-cell receptors pointing to a brain antigen-specificity of the growth restoring Th17 cell action (Kebir et al., 2007).”
BackgroundRole of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia
Subbanna, M., Shivakumar, V., Talukdar, P. M., Narayanaswamy, J. C., Venugopal, D., Berk, M., Varambally, S. S., Venkatasubramanian, G., & Debnath, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.016 · Cited by 43
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alshammari, M. A., Khan, M. R., Alsaad, A. M. S., & Attia, S. M. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.09.006 · Cited by 38
Functional and phenotypic heterogeneity of Th17 cells in health and disease
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Al-Bogami, M. M., Ong, V. H., Abraham, D., Williams, R. O., & Mageed, R. A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13032 · Cited by 41
“In experimental autoimmune encephalomyelitis in mice and in patients with multiple sclerosis, Th17 cells become pathogenic when they are induced to produce IFNγ.(31,32) Further studies have shown that murine Th17 cells in the gut mucosa can transdifferentiate to IL‐10‐producing regulatory T cells (Tr‐1 cells), a proce…”
BackgroundInfluentialIzadi, M., Tahmasebi, S., Pustokhina, I., Yumashev, A. V., Lakzaei, T., Alvanegh, A. G., Roshangar, L., Dadashpour, M., Yousefi, M., & Ahmadi, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102466 · Cited by 37
Das, U. N. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01173-8 · Cited by 39
Vascular biology: the role of sphingosine 1‐phosphate in both the resting state and inflammation
Swan, D. J., Kirby, J. A., & Ali, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01136.x · Cited by 38
“The effectiveness of FTY720 in this condition may be due to broader mechanisms of action than inhibition of migration of autoantigen-specific (particularly Th17 cells [103, 104]) lymphocytes to the CNS [105].”
BackgroundSun, C., Wei, L., Luo, F., Li, Y., Li, J., Zhu, F., Kang, P., Xu, R., Xiao, L., Liu, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048594 · Cited by 42
“Interestingly, several studies reported that regulatory T-cells could mediate neuroprotection through modulation of microglia oxidative stress and inflammation, while profound T-cell responses could exacerbate neuroinflammation and induce dopaminergic neurodegeneration [58–61].”
BackgroundFingolimod for the treatment of relapsing multiple sclerosis
Jeffery, D., Markowitz, C., Reder, A. T., Weinstock‐Guttman, B., & Tobias, K. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.193 · Cited by 38
Vitamin D Counteracts an IL-23–Dependent IL-17A+IFN- γ + Response Driven by Urban Particulate Matter
Mann, E. H., Ho, T.-R., Pfeffer, P., Matthews, N. C., Chevretton, E. B., Mudway, I., Kelly, F. J., & Hawrylowicz, C. M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0409oc · Cited by 38
Asthma and posttraumatic stress disorder (PTSD): Emerging links, potential models and mechanisms
Allgire, E., McAlees, J. W., Lewkowich, I. P., & Sah, R. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.001 · Cited by 42
Grunwald, C., Krętowska-Grunwald, A., Adamska-Patruno, E., Kochanowicz, J., Kułakowska, A., & Chorąży, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052589 · Cited by 43
“Similarly to Th17, Th22 might disturb the blood–brain barrier, leading to inflammation through recruitment of CD4+ T lymphocytes, which could be potentially meaningful in the pathogenesis of multiple sclerosis [118,122].”
BackgroundKol, A., Walker, N. J., Nordström, M., & Borjesson, D. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148568 · Cited by 41
Sphingosine-1 Phosphate and Central Nervous System
Martinꝉ, R., & Sospedra, M. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-05879-5_7 · Cited by 38
Crosstalk between the Producers and Immune Targets of IL-9
Do-Thi, V. A., Lee, J., Lee, H., & Kim, Y. S. (2020) · Immune Network · doi:10.4110/in.2020.20.e45 · Cited by 37
“Myelin-specific Th1 and/or Th17 cells are known to cause EAE through damage to the blood-brain barrier (41).”
BackgroundBlood–Brain Barrier Promotes Differentiation of Human Fetal Neural Precursor Cells
Chintawar, S., Cayrol, R., Antel, J. P., Pandolfo, M., & Prat, A. (2009) · Stem Cells · doi:10.1002/stem.25 · Cited by 36
Self-citationSeronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis
Sato, D. K., Callegaro, D., Lana–Peixoto, M. A., Nakashima, I., & Fujihara, K. (2014) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20140032 · Cited by 43
Fujii, C., Kondo, T., Ochi, H., Okada, Y., Hashi, Y., Adachi, T., Shin‐Ya, M., Matsumoto, S., Takahashi, R., Nakagawa, M., et al. (2016) · Scientific Reports · doi:10.1038/srep35314 · Cited by 37
Wang, A. A., Luessi, F., Neziraj, T., Pössnecker, E., Zuo, M., Engel, S., Hanuscheck, N., Florescu, A., Bugbee, E., Xianjie, I., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0295 · Cited by 41
“In support of this notion, T H 17 cells directly compromise the barrier between blood endothelium and the CNS parenchyma ( 69 ), allowing them to infiltrate preferentially into the deep white matter, as shown by Segal and colleagues ( 70 ).”
BackgroundReview: T helper 17 cells: Their role in glomerulonephritis
Ooi, J. D., Kitching, A. R., & Holdsworth, S. R. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01343.x · Cited by 40
“It is believed that Th17 cells use IL-22 to mediate local tissue inflammation as seen in mouse models of psoriasis(45) or possibly facilitate the influx of Th17 cells as IL-22 helps disrupt the blood-brain barrier and promotes Th17 cell infiltration into the central nervous system.(46) IL-22 also plays protective role…”
BackgroundZhao, W., Wang, Y., Wang, D., Sun, B., Wang, G., Wang, J., Kong, Q., Wang, Q., Peng, H., Jin, L., et al. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.06.009 · Cited by 36
Lee, P., Puppi, M., Schluns, K. S., Yu‐Lee, L., Dong, C., & Lacorazza, H. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301372 · Cited by 37
Fang, K., Zhang, L., Liu, Z., Yan, S., Xu, Z., Bai, J., Zhu, H., Lou, F., Cai, W., Sun, Y., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0179 · Cited by 35
iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles
Biasi, S. D., Simone, A. M., Nasi, M., Bianchini, E., Ferraro, D., Vitetta, F., Gibellini, L., Pinti, M., Giovane, C. D., Sola, P., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00555 · Cited by 35
“Our data on iNKT cells in SP-MS patients support the hypothesis that Th17 responses play a crucial role in the development of the progressive phases of MS (44, 48, 49) maybe, in part, via activation of iNKT cells, and the production of Th1 and Th17 cytokines.”
ResultA narrative review of psoriasis and multiple sclerosis: links and risks
Silfvast‐Kaiser, A., Homan, K. B., & Mansouri, B. (2019) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s186637 · Cited by 43
“As with IL-17, increased levels of TNF-alpha are found in both PsO and MS plaques, underlining the central role of these inflammatory mediators in both diseases.(6,37,38)”
BackgroundThe Ups and Downs of Metabolism during the Lifespan of a T Cell
Balyan, R., Gautam, N., & Gascoigne, N. R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217972 · Cited by 37
Permeability of the Blood–Brain Barrier after Traumatic Brain Injury: Radiological Considerations
Amoo, M., O’Halloran, P. J., Henry, J. H., Husien, M. B., Brennan, P., Campbell, M., Caird, J., & Curley, G. F. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2020.7545 · Cited by 38
Leal, F. E., Ndhlovu, L. C., Hasenkrug, A. M., Bruno, F. R., Carvalho, K. I., Wynn-Williams, H., Neto, W. K., Sanabani, S. S., Segurado, A. A. C., Nixon, D. F., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002028 · Cited by 41
“IL-17 also plays a pivotal role in the pathogenesis of HIV infection [50,82] and various inflammatory diseases [83], but conflicting results regarding frequency of Th17 and IL-17 production were described in HTLV-1 infection [43,44].”
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
Lolli, F., Martini, H., Citro, A., Franceschini, D., Portaccio, E., Amato, M. P., Mechelli, R., Annibali, V., Sidney, J., Sette, A., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-94 · Cited by 36
“; licensee BioMed Central Ltd Commons Attribution License (http://creativec reproduction in any medium, provided the or IL-17 produced by CD4 or CD8 T cells specific to myelin proteins (likely in response to IL-23 and granulocyte monocyte-colony stimulating factor, GM-CSF) plays a preponderant role in the autoimmune d…”
BackgroundInvestigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
Kalinowska, A., & Losy, J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.9.1267 · Cited by 36
Dolff, S., Quandt, D., Feldkamp, T., Jun, C., Mitchell, A., Hua, F., Specker, C., Kribben, A., Witzke, O., & Wilde, B. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2013.869830 · Cited by 38
Astrocyte-derived VEGF increases cerebral microvascular permeability under high salt conditions
Deng, Z., Zhou, L., Wang, Y., Liao, S., Huang, Y., Shan, Y., Tan, S., Zeng, Q., Peng, L., Huang, H., et al. (2020) · Aging · doi:10.18632/aging.103348 · Cited by 34
“The disruption of the BBB integrity is one of the key events under inflammatory CNS conditions, including cerebral ischemic injury and CNS immune diseases [11, 12].”
BackgroundTherapeutic potential of targeting IL-17 and its receptor signaling in neuroinflammation
Gautam, A. S., & Singh, R. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103517 · Cited by 36
Mangalam, A. K., Rattan, R., Suhail, H., Singh, J., Hoda, M. N., Deshpande, M., Fulzele, S., Đenić, A., Shridhar, V., Kumar, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501549 · Cited by 34
“integrity either by disrupting tight junctions (27) or by increasing production of reactive oxygen species in endothelial cells, resulting in upregulation of endothelial adhesion molecules and transmigration of inflammatory cells through the BBB (26).”
BackgroundColamatteo, A., Maggioli, E., Loiola, R. A., Sheikh, M. H., Calì, G., Bruzzese, D., Maniscalco, G. T., Centonze, D., Buttari, F., Lanzillo, R., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801683 · Cited by 37
“the pathogenesis of MS, namely CD4FOXP3 Treg cells and proinflammatory T CD4RORgt (Th17) cells (30, 31).”
BackgroundCao, Y., Yu, Y., Xue, B., Wang, Y., Chen, X., Beltz, T. G., Johnson, A. K., & Wei, S. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18219 · Cited by 42
Margetts, G., Kleidonas, S., Zaibi, N. S., Zaibi, M. S., & Edwards, K. D. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03605-1 · Cited by 38
“As noted above, IL-17 has also been linked to BBB function and integrity [17, 18].”
BackgroundInfluentialMohamed, Y. T., Salama, A., Rabie, M. A., & Fattah, M. A. A. E. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109571 · Cited by 36
Rolla, S., Ingoglia, G., Bardina, V., Silengo, L., Altruda, F., Novelli, F., & Tolosano, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203076 · Cited by 34
“Autoantigen-specific Th17 cells have been shown to break and transmigrate across the blood–brain barrier, and in the CNS induce inflammation by neutrophil recruitment (20) and killing of neurons (25).”
BackgroundArima, Y., Kamimura, D., Sabharwal, L., Yamada, M., Bando, H., Ogura, H., Atsumi, T., & Murakami, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/898165 · Cited by 36
“In addition, Kebir et al. reported that treatment with IL-17A increases the protein permeability of human brain endothelial cells and that this permeability is associated with a decrease in the expression of occludin and ZO-1 [7].”
BackgroundStanisavljević, S., Lukić, J., Momčilović, M. B., Miljković, M., Jevtić, B., Kojić, M., Golić, N., Stojković, M. M., & Miljković, D. M. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0159 · Cited by 36
“Mostly they stimulate other cells, such as macrophages and neutrophils, to execute CNS tissue destruction, yet some direct effects of these cytokines on CNS resident cells have been observed (Kurschus, 2015), such as induction of olygodendrocyte cell death and blood-brain barrier dysfunction (Kebir et al., 2007; Varta…”
BackgroundAbdelrahman, R. S., & El‐Tanbouly, G. S. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115931 · Cited by 33
Soares, G. B., Mahmoud, O., Yosipovitch, G., & Mochizuki, H. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19813 · Cited by 39
“105 These changes may enable circulating proinflammatory cytokines and immune cells, including Th17 and IL-17, to cross the BBB and enter the CNS to promote neuroinflammation.”
BackgroundYoung, K. G., MacLean, S., Dudani, R., Krishnan, L., & Sad, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100695 · Cited by 35
Rodríguez, N., Morer, Á., González‐Navarro, E. A., Serra‐Pages, C., Boloc, D., Torres, T., Martínez-Pinteño, A., Mas, S., Lafuente, A., Gassó, P., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.022 · Cited by 35
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alqahtani, F., Alhoshani, A., Alasmari, F. F., Alsaleh, N. B., & Attia, S. M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172859 · Cited by 33
Orsini, A. A., Foiadelli, T., Costagliola, G., Michev, A., Consolini, R., Vinci, F., Peroni, D. G., Striano, P., & Savasta, S. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106588 · Cited by 34
Kim, G., Kim, W., Lim, S., Lee, H., Koo, J., Nam, K.-H., Kim, S., Park, S., & Choi, J. (2021) · Advanced Science · doi:10.1002/advs.202004973 · Cited by 37
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
Maglione, A., Zuccalà, M., Tosi, M., Clerico, M., & Rolla, S. (2021) · Genes · doi:10.3390/genes12081181 · Cited by 34
Yang, R., Chen, J., Qu, X., Liu, H., Wang, X., Tan, C., Chen, H., & Wang, X. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00668 · Cited by 35
Korn, T., Mitsdoerffer, M., & Kuchroo, V. K. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2008_17 · Cited by 45
Opdenakker, G., & Damme, J. V. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.11.005 · Cited by 34
“Meanwhile, insights into the producer cell types of the cytokines involved in the autoimmune process have increased enormously, and Th1, Th2, Th17 and Treg cells have been defined in terms of regulation of transcription factors and resulting cytokine productions [21–24].”
BackgroundInfluentialEsendağlı, G., Kurne, A., Sayat, G., Kılıç, A. K., Güç, D., & Karabudak, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.10.009 · Cited by 33
“As also demonstrated in experimental allergic encephalomyelitis (EAE) models, Th17 cells migrate more efficiently than Th1 cells and display cytotoxic activity against neurons (Kebir et al., 2007).”
BackgroundDrulovic, J. S., Savić, E., Pekmezovic, T. D., Mesaroš, Š., Stojsavljević, N., Dujmović, I., Kostić, J., Vasić, V., Stojković, M. M., & Popadic, D. M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.010 · Cited by 38
“The significance of IL-17 in the pathogenesis of MS has not been well defined yet, although cytokine has been detected in the active brain lesions and cerebrospinal fluid of MS patients (Kebir et al., 2007; Lock et al., 2002; Matusevicius et al., 1999).”
Ma, H., Xu, J., Liu, X., Zhu, Y., Gao, B., Karin, M., Tsukamoto, H., Jeste, D. V., Grant, I., Roberts, A. J., et al. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0097-3 · Cited by 34
Huang, J., Han, S. H., Sun, Q., Zhao, Y., Liu, J., Yuan, X., Mao, W., Peng, B., Liu, W., Yin, J., et al. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0158-2 · Cited by 34
“Th17 cell secreted IL-17 is highly expressed in the CNS lesions of MS patients [49], and IL-17 contributes to the disruption of the BBB during EAE [16].”
Jha, M. K., Minhajuddin, A., Gadad, B. S., & Trivedi, M. H. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx060 · Cited by 33
Chorioamnionitis, IL‐17A, and fetal origins of neurologic disease
Lawrence, S. M., & Wynn, J. L. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12803 · Cited by 37
Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity
Lindner, M., Klotz, L., & Wiendl, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14339 · Cited by 34
miR-340 Alleviates Psoriasis in Mice through Direct Targeting of IL-17A
Bian, J., Liu, R., Fan, T., Liao, L., Wang, S., Geng, W., Wang, T., Shi, W., & Ruan, Q. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800189 · Cited by 35
Shi, Z., Chen, Y., Lu, C., Dong, L.-M., Lv, J.-W., Tuo, Q.-H., Qin, L., Cheng, S.-W., Bu, L.-L., Lin, N., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.002 · Cited by 32
The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
Meng, X.-T., Shi, Y.-Y., Zhang, H., & Zhou, H. (2020) · Journal of Ophthalmology · doi:10.1155/2020/6917185 · Cited by 37
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
Lee, C., & Chan, K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010120 · Cited by 34
“T cell abnormalities detected in MS include an increased number of circulating CD4+ Th1 and Th17 cells with enhanced effector functions [22,23], insufficient function of regulatory T cells, decreased expression of forkhead box protein P3 (FOXP3) by regulatory T cells [24], and the resistance of…”
BackgroundNFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis
Reppert, S., Zinser, E., Holzinger, C., Sandrock, L., Koch, S., & Finotto, S. (2015) · European Journal of Immunology · doi:10.1002/eji.201445150 · Cited by 35
Increased Th17 response to myelin peptides in pediatric MS
Vargas-Lowy, D., Kivisäkk, P., Gandhi, R., Raddassi, K., Soltany, P., Gorman, M., Khoury, S. J., & Chitnis, T. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.008 · Cited by 32
“the blood–brain barrier [27] and therefore may be important in the initiation of disease within the CNS.”
BackgroundZhang, W., Feng, J., Zhou, R., Ye, L.-Y., Liu, H., Liang, P., Lou, J., & Li, C.-H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.040 · Cited by 32
IL22/IL-22R Pathway Induces Cell Survival in Human Glioblastoma Cells
Akil, H., Abbaci, A., Lalloué, F., Bessette, B., Costes, L. M. M., Domballe, L., Charreau, S., Guilloteau, K., Karayan, L., Bernard, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119872 · Cited by 38
“Kebir and colleagues reported the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells during multiple sclerosis lesions and in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis [28].”
BackgroundKozela, E., Haj, C. G., Hanuš, L., Chourasia, M., Shurki, A., Juknat, A., Kaushansky, N., Mechoulam, R., & Vogel, Z. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12637 · Cited by 35
“Indeed, IL-17 appears to be a key mediator of EAE/MS neuroinflammation (19,20) and a decrease in Th17 function delays the onset of EAE and reduces its severity (21).”
BackgroundBoswellic acids reduce T h17 differentiation via blockade of IL ‐1β‐mediated IRAK 1 signaling
Stürner, K. H., Verse, N., Yousef, S., Martinꝉ, R., & Sospedra, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201343629 · Cited by 37
Luo, H., Broux, B., Wang, X., Hu, Y., Ghannam, S., Jin, W., Larochelle, C., Prat, A., & Wu, J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.013 · Cited by 36
Self-citationSałkowska, A., Karaś, K., Walczak‐Drzewiecka, A., Dastych, J., & Ratajewski, M. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.6a0617-217r · Cited by 34
“In recent years, Th17 cells have been identified as pathogenic cells that induce tissue damage in numerous autoimmune diseases, including multiple sclerosis [11], rheumatoid arthritis [12], psoriasis [13], Grave’s disease [14], and inflammatory bowel disease [15].”
BackgroundFunction of Act1 in IL-17 Family Signaling and Autoimmunity
Wu, L., Zepp, J. A., & Li, X. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_13 · Cited by 36
Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies
Yan, X.-Z., Lai, L., Ao, Q., Tian, X.-H., & Zhang, Y.-H. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210823110004 · Cited by 32
“According to reports, the endothelial cells of BBB (BBB-ECs) express IL17A receptors, and the binding of IL-17A to the receptors causes the disruption of BBB tight junctions [60].”
BackgroundIL-17 in the Rheumatologist’s Line of Sight
Truchetet, M., Mossalayi, M. D., & Boniface, K. (2013) · BioMed Research International · doi:10.1155/2013/295132 · Cited by 32
“Th17 cells are linked to the pathogenesis of various human autoimmune and inflammatory diseases, and IL-17, IL-17F, IL-22, and IL-23 levels are increased in RA, psoriasis, multiple sclerosis, and IBD [4, 17, 72–75].”
BackgroundOne, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
Sambucci, M., Gargano, F., Guerrera, G., Battistini, L., & Borsellino, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02947 · Cited by 32
“Once in the tissue, these cells can become reactivated following interaction with resident antigen-presenting cells (APCs), such as microglia or myeloid cells, and can start producing inflammatory cytokines which increase BBB permeability and initiate the cascade of infiltration by pathogenic proinflammatory cells, an…”
BackgroundThe hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation
Benallegue, N., Kébir, H., Kapoor, R., Crockett, A. M., Li, C., Cheslow, L., Abdel-Hakeem, M. S., Gesualdi, J., Miller, M. C., Wherry, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab083 · Cited by 31
“vated within the CNS to drive multiple sclerosis and EAE disease pathology.(32,36,37) First, we found that none of the SHH concentrations”
BackgroundRORγt-Expressing Pathogenic CD4+ T Cells Cause Brain Inflammation during Chronic Colitis
Mickael, M., Bhaumik, S., Chakraborti, A., Umfress, A., van Groen, T., Macaluso, M., Totenhagen, J. W., Sorace, A. G., Bibb, J. A., Standaert, D. G., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100869 · Cited by 33
Blethen, K. E., Sprowls, S. A., Arsiwala, T. A., Wolford, C. P., Panchal, D. M., Fladeland, R. A., Glass, M. J., Dykstra, L. P., Kielkowski, B. N., Blackburn, J. R., et al. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02215-6 · Cited by 35
“Production of IL-17 has been shown to decrease the expression of tight junction proteins in mouse models of multiple sclerosis [48].”
BackgroundMengozzi, A., Ciuceis, C. D., Dell’Oro, R., Georgiopoulos, G. A., Lazaridis, A. A., Nosalski, R., Pavlidis, G., Tual‐Chalot, S., Rosei, C. A., Anyfanti, P., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003503 · Cited by 34
“com Microcerebrovascular endothelial cell activation and BBB leakage promote the migration and accumulation of proinflammatory macrophages [244] and T cells [245,246] in perivascular space (Figure 2, Supplemental Digital Content, http://links.”
Background
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.